AOS - AOS

Últimas noticias sobre A.O. Smith (NYSE:AOS) Bolsa

A.O. Smith

A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

PAYX

Explora las acciones más sobrevendidas del sector industrial, como Paychex, Sunrun y A O Smith. Por qué podrían ser una oportunidad de compra

Acciones industriales sobrevendidas: Oportunidades en PAYX, RUN y AOS

A.O. Smith Corp

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega Semiconductor Ltd

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Paychex Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>)</h3>
<ul>
<li>On Nov. 19, JP Morgan analyst Tien-Tsin Huang maintained Paychex with an Underweight rating and raised the price target from $133 to $139. The company's stock fell around 4% over the past five days and has a <a href="https://www.benzinga.com/quote/PAYX">52-week low of $114.72</a>.</li>
<li>RSI Value: 29.58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>PAYX Price Action: Shares of Paychex fell 3.2% to close at $135.86 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1">latest PAYX news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="908" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164.png" alt="" class="wp-image-699579" style="width:617px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074317/image-164-768x719.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<h3 class="wp-block-heading">Sunrun Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Dec. 17, Goldman Sachs analyst Brian Lee maintained Sunrun with a Buy and lowered the price target from $19 to $17. The company's stock fell around 12% over the past five days and <a href="https://www.benzinga.com/quote/RUN">has a 52-week low</a> of $9.13.</li>
<li>RSI Value: 28.40</li>
<li>RUN Price Action: Shares of Sunrun fell 9.1% to close at $9.15 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"> trend in RUN stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165.png" alt="" class="wp-image-699581" style="width:630px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074410/image-165-768x706.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">A O Smith Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>)</h3>
<ul>
<li>On Dec. 11, Stifel analyst Nathan Jones maintained A.O. Smith with a Buy and lowered the price target from $91 to $90. The company's stock fell around 5% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/AOS">low of $68.89.</a></li>
<li>RSI Value: 25.09</li>
<li>AOS Price Action: Shares of A O Smith fell 2.7% to close at $68.91 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1">breakout in AOS shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="927" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166.png" alt="" class="wp-image-699582" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19074507/image-166-768x693.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42553288/top-3-tech-and-telecom-stocks-that-may-crash-this-month">Top 3 Tech And Telecom Stocks That May Crash This Month</a></li>
</ul>

Top 3 Industrials Stocks Which Could Rescue Your Portfolio For December

Throughout the last three months, 6 analysts have evaluated A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.33, a high estimate of $91.00, and a low estimate of $78.00. This current average has decreased by 1.96% from the previous average price target of $85.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1733929267_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of A.O. Smith by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to A.O. Smith. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of A.O. Smith's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of A.O. Smith's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on A.O. Smith analyst ratings.</a>
<h2>Unveiling the Story Behind A.O. Smith</h2>
A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.
<h3>Financial Insights: A.O. Smith</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Challenges: A.O. Smith's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -3.72%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: A.O. Smith's net margin is impressive, surpassing industry averages. With a net margin of 13.31%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 6.27%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): A.O. Smith's ROA excels beyond industry benchmarks, reaching 3.78%. This signifies efficient management of assets and strong financial health.
Debt Management: A.O. Smith's debt-to-equity ratio is below the industry average at 0.07, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Where A.O. Smith Stands With Analysts

Stifel analyst Nathan Jones maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Buy and lowers the price target from $91 to $90.

Price Target

Stifel Maintains Buy on A.O. Smith, Lowers Price Target to $90

Citigroup analyst Andrew Kaplowitz maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Neutral and lowers the price target from $85 to $78.

Citigroup Maintains Neutral on A.O. Smith, Lowers Price Target to $78

<h3 class="wp-block-heading">New On The Block</h3>
Evolent Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) is <a href="https://www.benzinga.com/m-a/24/08/40529349/evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms">reportedly up for sale</a>. The Arlington, Virginia-based software provide initiated an auction process after receiving takeover inquiries. Among the potential suitors are TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>), Clayton, Dubilier &amp; Rice, and KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>). Reuters reported that health insurer Elevance Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) may join forces with a private equity partner to pursue a deal.
Kronos Bio Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRON#NASDAQ">KRON</a>), a company focused on developing therapies for cancer, is exploring &#8220;strategic alternatives,&#8221; including an acquisition or merger.The San Mateo, Califonia-based company reported $124.9 million in cash reserves as of Sept. 30. 
Saint-Gobain (PARIS:<a class="ticker" href="https://www.benzinga.com/stock/SGO#PARIS">SGO</a>) is considering a sale of its auto glass unit, which could fetch up to 2.5 billion euro ($2.6 billion), per <a href="https://www.bloomberg.com/news/articles/2024-11-13/st-gobain-is-said-to-weigh-2-5-billion-sale-of-auto-glass-unit">Bloomberg</a>. The company is reportedly considering this strategic move as part of its broader business evaluation. This sale aligns with Saint-Gobain&#8217;s efforts to streamline its operations and focus on core business areas.
Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is seeking to <a href="https://www.bloomberg.com/news/articles/2024-11-13/shell-aims-to-sell-majority-stake-in-carbon-offsets-business?srnd=phx-deals">jettison</a> a majority of its carbon offsets portfolio. The company first launched the portfolio of offsets, which covers dozens of projects, <a href="https://www.bloomberg.com/news/features/2023-08-31/shell-silently-abandoned-its-100-million-a-year-plan-to-offset-co2-emissions" target="_blank" rel="noreferrer noopener">in 2018</a>. 
Unilever (LSE: ULVR) is exploring the sale of some Dutch food brands, including Unox soups and Conimex seasonings. According to Reuters, the company will instead focus on its biggest &#8220;power&#8221; labels.
See Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42024210/benzinga-bulls-and-bears-tesla-disney-gold-and-hedge-funds-project-bitcoin-to-hit-100k-150k">Benzinga Bulls And Bears: Tesla, Disney, Gold — And Hedge Funds Project Bitcoin To Hit $100K-$150K</a>
<h3 class="wp-block-heading">Bankruptcy Block</h3>
Alex Jones&#8217;s media company, Infowars, is now the property of satirical publication The Onion. The publication&#8217;s backers were none other than the families <a href="https://www.benzinga.com/media/24/11/41982446/jokes-on-jones-onion-backed-by-families-of-sandy-hook-victims-buys-info-wars">of Sandy Hook victims</a>. Observers praised the deal as poetic justice, considering Jones owes over $1 billion in defamation judgments against those families. Jones, who <a href="https://www.benzinga.com/news/23/12/36168941/elon-musks-controversial-move-alex-jones-returns-to-x-after-user-vote">has garnered sympathy from</a> right-wing personalities like Elon Musk and Tucker Carlson, confirmed the acquisition in a visibly distressed social media video, blaming &#8220;Democrats.&#8221;
Diamond Sports Group&#8216;s restructuring will include reducing its debt from nearly $9 billion to $200 million, <a href="https://www.espn.com/mlb/story/_/id/42388454/diamond-sports-group-emerges-bankruptcy">ESPN</a> reports. The restructuring plan received what Diamond categorized as &#8220;nearly unanimous support&#8221; from debt holders. Diamond, currently possessing $100 million in liquidity, will emerge from bankruptcy and operate as a stand-alone entity. Sinclair, the parent company, took on $8 billion in debt to buy regional channels from Fox for $10.6 billion in 2019. That debt contributed to Diamond&#8217;s bankruptcy.
<h3 class="wp-block-heading">Updates From The Block</h3>
Currently, there are no concrete indications that Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) is actively pursuing a sale. Recent speculation regarding Humana being acquired by Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) was definitively addressed, with Cigna explicitly stating that it is <a href="https://www.benzinga.com/general/health-care/24/11/41877573/cigna-not-pursuing-humana-merger-stock-soars">not pursuing a merger</a> with Humana at this time. This clarification came after rumors reignited post-election, driven by the potential for more lenient antitrust reviews under the new <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">Republican administration and Congress</a>.
Spirit Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) is no longer in deal talks with Frontier Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>). It&#8217;s now in advanced discussions with bondholders to finalize a bankruptcy plan. The carrier continues to struggle with mounting losses and looming debt maturities. A bankruptcy filing is expected to happen within weeks, according to <a href="https://www.benzinga.com/news/earnings/24/11/41932146/spirit-airlines-nears-bankruptcy-creditors-may-approve-equity-cancellation-heres-what-it-means-for-investors-as-shares-fall-with-a-thud">the Wall Street Journal</a>.
MEI Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEIP#NASDAQ">MEIP</a>) continues to explore M&amp;A opportunities, hiring Oppenheimer &amp; Co., Inc. as an exclusive financial advisor to assist the process. During the first quarter of fiscal year 2025, the company commenced cash preservation efforts that include a reduction-in-force, which will continue in stages as the Company's operational and strategic direction evolves.
<h3 class="wp-block-heading">Notes From The Block</h3>
Wall Street anticipates a surge in M&amp;A as Republicans take control of Congress and deregulate. Analysts expect Federal Trade Commission Chair Lina Khan's removal, which could ease antitrust scrutiny. Bank of America highlights that Republican administrations, like President-elect Donald Trump&#8216;s, historically foster over 50% more financial sector M&amp;A activity compared to Democratic ones. 
Bank of America also predicts that 2025 could mark a better year for M&amp;A as rate cuts take effect and economic conditions stabilize. Here&#8217;s a list of five potential targets the bank compiled. For the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">full list, click here</a>.
<figure class="wp-block-table"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Sector</th>
<th>Market Cap ($M)</th>
<th>Free Cash Flows-to-Enterprise Value (%)</th>
<th>Long-Term Growth Expectations (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)</td>
<td>Health Care</td>
<td>13,932</td>
<td>4.4</td>
<td>25.3</td>
</tr>
<tr>
<td>Ralph LaurenCorp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>)</td>
<td>Consumer Disc.</td>
<td>12,473</td>
<td>5.99</td>
<td>10.5</td>
</tr>
<tr>
<td>Paramount Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NYSE">PARA</a>)</td>
<td>Comm. Services</td>
<td>7,250</td>
<td>3.4</td>
<td>46.4</td>
</tr>
<tr>
<td>Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>)</td>
<td>Technology</td>
<td>14,480</td>
<td>6.39</td>
<td>12.7</td>
</tr>
<tr>
<td>Hasbro Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>)</td>
<td>Consumer Disc.</td>
<td>9,215</td>
<td>3.6</td>
<td>27.5</td>
</tr>
</tbody>
</table>
</figure>
For last week&#8217;s Deal Dispatch, <a href="https://www.benzinga.com/news/asset-sales/24/11/41866114/deal-dispatch-prison-companies-in-focus-post-election-tripadvisor-boasts-11b-in-cash">click here</a>.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41699259/nvidia-rides-ai-wave-to-replace-intel-on-dow-jones-industrial-average-ending-its-25-year-run">Nvidia Rides AI Wave To Replace Intel On Dow Jones Industrial Average, Ending Its 25-Year Run</a></li>
</ul>

AAUKF

APTV

ATSG

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

FFIV

KRON

MEIP

NISTF

PARA

PARIS:SGO

ROIC

SAVE

SHEL

SLGWF

SLNG

TRIP

TSX:SGO

ULCC

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul

With Republicans taking control of Congress, Wall Street is buzzing about a potential boom in mergers and acquisitions (M&amp;A) under the upcoming<a href="https://www.benzinga.com/topic/donald-trump"> Trump administration.</a>
Bank of America analysts see brighter days ahead for deal-making, anticipating that Trump could remove Federal Trade Commission Chair Lina Khan, whose aggressive antitrust stance has been a major roadblock for M&amp;A activity across sectors.
Combined with favorable macro factors and investor demand for capex and M&amp;A over debt paydown, there are plenty of reasons to believe that 2025 and beyond could see significant deal activity.
<h3 class="wp-block-heading">Banks And Biotech: Two Key Sectors To Watch</h3>
Analysts at Bank of America's U.S. banks team are particularly bullish about the M&amp;A prospects for financials, which have historically enjoyed more than 50% higher deal activity under Republican administrations than Democratic ones. With regulatory scrutiny expected to loosen, the landscape is ripe for a surge in bank deals.
Deal activity in biotech has already started picking up, especially in smaller acquisitions. Big Pharma faces mounting pressure to offset patent expirations, so it&#8217;s hunting for acquisition targets to replenish its drug pipelines. Lower rates and potential deregulation could further fuel biotech M&amp;A as we head into 2025.
"The election results could lead to a less restrictive regulatory environment, which may open the door for more bank mergers and acquisitions,&#8221; Jill Carey Hall, CFA, a Bank of America analyst, said. 
<h3 class="wp-block-heading">Macro Factors: Green And Yellow Lights for M&amp;A</h3>
Several macroeconomic factors support a cyclical pick-up in M&amp;A activity. 
Strong equity market returns, cheap small-cap valuations relative to large caps and tight credit spreads all suggest a favorable environment for deal-making.
Not all signals are flashing green. Slowing GDP growth, rate uncertainty and high volatility could throw some caution flags. Long-term growth expectations for small caps, though improved, still remain below average.
Bank of America's credit strategists predict that 2025 could be a better year for M&amp;A activity as rate cuts begin to materialize and volatility subsides. 
"Sponsors are sitting on a pile of uncalled capital, and there's a real incentive to deploy it in a friendlier economic environment," Hall said.
<h3 class="wp-block-heading">Who Stands To Gain: Small-Cap Targets, Large-Cap Acquirers</h3>
With large deals on the decline, smaller targets have become the prime candidates for takeovers. 
Aggregate deal value has been falling in recent years as mega-cap deals have dried up and smaller, more manageable transactions have become the norm.
This trend has paid off for both sides: small-cap targets have outperformed post-announcement and large-cap acquirers have seen record one-day gains in 2023 despite paying higher deal premiums.
This pattern suggests that investors are rewarding companies that buy growth, especially in today's uncertain economic landscape.
<h3 class="wp-block-heading">10 Potential M&amp;A Candidates Among Large Caps</h3>
Bank of America's latest screening of potential M&amp;A candidates includes high-growth, undervalued names, each with distinct value propositions that may appeal to suitors looking for long-term growth.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Sector</th>
<th>Market Cap ($M)</th>
<th>Free Cash Flows-to-Enterprise Value (%)</th>
<th>Long-Term Growth Expectations (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>)</td>
<td>Health Care</td>
<td>13,932</td>
<td>4.4</td>
<td>25.3</td>
</tr>
<tr>
<td>Ralph Lauren Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>)</td>
<td>Consumer Disc.</td>
<td>12,473</td>
<td>5.99</td>
<td>10.5</td>
</tr>
<tr>
<td>Paramount Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NYSE">PARA</a>)</td>
<td>Comm. Services</td>
<td>7,250</td>
<td>3.4</td>
<td>46.4</td>
</tr>
<tr>
<td>Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>)</td>
<td>Technology</td>
<td>14,480</td>
<td>6.39</td>
<td>12.7</td>
</tr>
<tr>
<td>Hasbro Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>)</td>
<td>Consumer Disc.</td>
<td>9,215</td>
<td>3.6</td>
<td>27.5</td>
</tr>
<tr>
<td>F5 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>)</td>
<td>Technology</td>
<td>13,431</td>
<td>6.39</td>
<td>9.9</td>
</tr>
<tr>
<td>DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) </td>
<td>Health Care</td>
<td>11,976</td>
<td>5.39</td>
<td>15.4</td>
</tr>
<tr>
<td>BorgWarner Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>)</td>
<td>Consumer Disc.</td>
<td>7,316</td>
<td>6.5</td>
<td>12.0</td>
</tr>
<tr>
<td>Aptiv plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>)</td>
<td>Consumer Disc.</td>
<td>13,143</td>
<td>4.4</td>
<td>23.7</td>
</tr>
<tr>
<td>A. O. Smith Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>)</td>
<td>Industrials</td>
<td>10,895</td>
<td>2.3</td>
<td>10.0</td>
</tr>
</tbody>
</table>
</figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41950023/us-stock-markets-equity-risk-premium-disappears-should-you-sell-now">US Stock Market&#8217;s Equity Risk Premium Disappears: Should You Sell Now?</a></li>
</ul>
Photo by Capri23auto from Pixabay

Analyst Color

Large Cap

Politics

Small Cap

Federal Reserve

Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates

A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $83.0, along with a high estimate of $91.00 and a low estimate of $80.00. This current average is unchanged from the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2024/1729710059_0_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive A.O. Smith is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to A.O. Smith. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of A.O. Smith's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of A.O. Smith's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on A.O. Smith analyst ratings.</a>
<h2>Get to Know A.O. Smith Better</h2>
A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells majorly in Asian countries and operates sales offices to expand distribution and market its product portfolio.
<h3>A.O. Smith's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining A.O. Smith's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.61% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: A.O. Smith's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 15.25%, the company may face hurdles in effective cost management.
Return on Equity (ROE): A.O. Smith's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 8.24%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): A.O. Smith's ROA excels beyond industry benchmarks, reaching 4.9%. This signifies efficient management of assets and strong financial health.
Debt Management: A.O. Smith's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.09.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 4 Analyst Recommendations For A.O. Smith

Stifel analyst Nathan Jones maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Buy and lowers the price target from $92 to $91.

Stifel Maintains Buy on A.O. Smith, Lowers Price Target to $91

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Alexander Goldfarb upgraded the rating for BXP, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>) from Neutral to Overweight and raised the price target from $78 to $105. BXP shares closed at $86.82 on Tuesday. <a href="https://www.benzinga.com/quote/bxp/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Andrew Boone upgraded Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) from Market Perform to Market Outperform and announced a $17 price target. Snap shares closed at $9.98 on Tuesday. <a href="https://www.benzinga.com/quote/snap/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Argus Research analyst David Coleman upgraded the rating for Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) from Hold to Buy. Alcoa shares closed at $42.02 on Tuesday. <a href="https://www.benzinga.com/quote/aa/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Damian Karas upgraded A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) from Sell to Neutral and raised the price target from $75 to $80. A.O. Smith shares closed at $78.21 on Tuesday. <a href="https://www.benzinga.com/quote/aos/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Eric Coldwell upgraded the rating for Quest Diagnostics Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) from Neutral to Outperform and boosted the price target from $157 to $182. Quest Diagnostics shares closed at $157.47 on Tuesday. <a href="https://www.benzinga.com/quote/dgx/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone">Dow Edges Lower As Investors Watch Earnings Reports With Caution: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Upgrades

SNAP

This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Guggenheim analyst Gregory Francfort downgraded the rating for McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) from Buy to Neutral and announced a $285 price target. McDonald&#8217;s shares closed at $314.69 on Tuesday. <a href="https://www.benzinga.com/quote/mcd/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst J. Bruce Chan downgraded TFI International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) from Buy to Hold and lowered the price target from $158 to $142. TFI International shares closed at $135.89 on Tuesday. <a href="https://www.benzinga.com/quote/tfii/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Janney Montgomery Scott analyst Sean Milligan downgraded the rating for Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Buy to Neutral and announced a price target of $83. Enphase Energy shares closed at $92.23 on Tuesday. <a href="https://www.benzinga.com/quote/enph/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>DA Davidson analyst Matt Summerville downgraded A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) from Buy to Neutral and announced a price target of $80. A.O. Smith shares closed at $78.21 on Tuesday. <a href="https://www.benzinga.com/quote/aos/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Eric Coldwell downgraded Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) from Outperform to Neutral and slashed the price target from $413 to $349. Medpace shares closed at $326.54 on Tuesday. <a href="https://www.benzinga.com/quote/medp/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying MCD stock? Here&#8217;s what analysts think: 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone">Dow Edges Lower As Investors Watch Earnings Reports With Caution: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Downgrades

ENPH

MEDP

TFII

This McDonald's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Baird analyst Michael Halloran maintains A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) with a Neutral and lowers the price target from $82 to $81.

Baird Maintains Neutral on A.O. Smith, Lowers Price Target to $81

UBS analyst Damian Karas upgrades A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) from Sell to Neutral and raises the price target from $75 to $80.

UBS Upgrades A.O. Smith to Neutral, Raises Price Target to $80

DA Davidson analyst Matt Summerville downgrades A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) from Buy to Neutral and announces $80 price target.

DA Davidson Downgrades A.O. Smith to Neutral, Announces $80 Price Target

Outlook
2024 Outlook
(in millions except per share amounts)
<table border="0" cellpadding="1" cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
2023
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="2" rowspan="1">
2024 Outlook
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
Actual
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
Low End
</td>
<td colspan="1" rowspan="1">
High End
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net sales
</td>
<td colspan="1" rowspan="1">
$&nbsp; &nbsp;3,853
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
$ 3,800
</td>
<td colspan="1" rowspan="1">
$ 3,900
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Diluted earnings per share
</td>
<td colspan="1" rowspan="1">
$&nbsp; &nbsp; &nbsp;3.69
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
$&nbsp;&nbsp; 3.70
</td>
<td colspan="1" rowspan="1">
$&nbsp;&nbsp; 3.85
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted earnings per share
</td>
<td colspan="1" rowspan="1">
$&nbsp; &nbsp; 3.811
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
$&nbsp;&nbsp; 3.70
</td>
<td colspan="1" rowspan="1">
$&nbsp;&nbsp; 3.85
</td>
</tr>
</tbody>
</table>
<table border="0" cellpadding="1" cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
1&nbsp;&nbsp;&nbsp;&nbsp;Excludes restructuring and impairment expenses. See accompanying GAAP to Non-GAAP reconciliations
</td>
</tr>
</tbody>
</table>
&quot;Because we expect consumer demand to remain challenged in&nbsp;China&nbsp;through the end of the year and we are cautious about&nbsp;North America&nbsp;residential and commercial water heater end-market demand, we announced on&nbsp;October 11, and reaffirm today, that we lowered our sales outlook for 2024 to be approximately flat to last year. We also lowered our full year EPS outlook to a range of between&nbsp;$3.70&nbsp;and&nbsp;$3.85, a year-over-year decline of 1% over 2023 adjusted EPS, at the midpoint,&quot; stated Wheeler. &quot;Our improved lead times are expected to continue through the remainder of the year, and we have adjusted our&nbsp;North America&nbsp;residential and commercial water heater facilities to improve production efficiencies at lower levels.&quot;

Earnings

Guidance

A.O. Smith Reduces 2024 Adjusted EPS Outlook To $3.70-$3.85 (Prior $3.95 - $4.10) Vs. $3.82 Est.; Sees Net Sales Of $3.80B-$3.90B Vs. $3.868B Est.

A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) reported quarterly earnings of $0.82 per share which missed the analyst consensus estimate of $0.83 by 1.2 percent. This is a 8.89 percent decrease over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $902.600 million which missed the analyst consensus estimate of $904.732 million by 0.24 percent. This is a 3.72 percent decrease over sales of $937.500 million the same period last year.

Earnings Misses

A.O. Smith Q3 2024 Adj. EPS $0.82 Misses $0.83 Estimate, Sales $902.600M Miss $904.732M Estimate

A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) is preparing to release its quarterly earnings on Tuesday, 2024-10-22. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect A.O. Smith to report an earnings per share (EPS) of $0.95.
Investors in A.O. Smith are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
The company's EPS missed by $0.00 in the last quarter, leading to a 0.36% increase in the share price on the following day.
Here's a look at A.O. Smith's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.06</td>
<td>0.98</td>
<td>0.95</td>
<td>0.8</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.06</td>
<td>1</td>
<td>0.97</td>
<td>0.9</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729522885_0.png" alt="eps graph" />
<h3>Tracking A.O. Smith's Stock Performance</h3>
Shares of A.O. Smith were trading at $78.75 as of October 18. Over the last 52-week period, shares are up 18.16%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Insights on A.O. Smith</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on A.O. Smith.
The consensus rating for A.O. Smith is Buy, derived from 2 analyst ratings. An average one-year price target of $94.0 implies a potential 19.37% upside.
<h3>Peer Ratings Comparison</h3>
The below comparison of the analyst ratings and average 1-year price targets of Fortune Brands, Advanced Drainage Systems and Allegion, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>For Fortune Brands, analysts project an Buy trajectory, with an average 1-year price target of $91.33, indicating a potential 15.97% upside.</li>
<li>The prevailing sentiment among analysts is an Outperform trajectory for Advanced Drainage Systems, with an average 1-year price target of $188.25, implying a potential 139.05% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Allegion, with an average 1-year price target of $138.2, suggesting a potential 75.49% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
In the peer analysis summary, key metrics for Fortune Brands, Advanced Drainage Systems and Allegion are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>A.O. Smith</td>
<td>Buy</td>
<td>6.61%</td>
<td>$396M</td>
<td>8.24%</td>
</tr>
<tr>
<td>Fortune Brands</td>
<td>Buy</td>
<td>6.56%</td>
<td>$541M</td>
<td>5.81%</td>
</tr>
<tr>
<td>Advanced Drainage Systems</td>
<td>Outperform</td>
<td>4.79%</td>
<td>$332.45M</td>
<td>12.28%</td>
</tr>
<tr>
<td>Allegion</td>
<td>Neutral</td>
<td>5.82%</td>
<td>$428.30M</td>
<td>11.20%</td>
</tr>
</tbody>
</table>

Key Takeaway:
A.O. Smith ranks highest in Gross Profit and Revenue Growth among its peers. It is in the middle for Return on Equity.
<h3>All You Need to Know About A.O. Smith</h3>
A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells majorly in Asian countries and operates sales offices to expand distribution and market its product portfolio.
<h3>Breaking Down A.O. Smith's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: A.O. Smith's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 6.61%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: A.O. Smith's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 15.25%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): A.O. Smith's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 8.24%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): A.O. Smith's ROA excels beyond industry benchmarks, reaching 4.9%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.09, A.O. Smith adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/AOS/earnings">To track all earnings releases for A.O. Smith visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into A.O. Smith's Upcoming Earnings

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 350 points on Friday.
The Dow traded up 0.86% to 42,820.94 while the NASDAQ rose 0.35% to 18,346.63. The S&amp;P 500 also rose, gaining, 0.58% to 5,813.55.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41290375/how-to-earn-500-a-month-from-bank-of-america-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Bank of America Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares jumped by 1.9% on Friday.
In trading on Friday, consumer discretionary shares fell by 0.3%.
Top Headline
BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) reported better-than-expected third-quarter results.
Revenue growth of 15% Y/Y to $5.197 billion, beating the consensus of $5.007 billion. Adjusted EPS increased 5% Y/Y to $11.46, beating the consensus of $10.38.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) shares shot up 194% to $6.21. The company priced its $10.8 million public offering of 27 million ordinary shares at $0.40 per share.</li>
<li>Shares of Pacific Biosciences of California Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) got a boost, surging 30% to $2.0093 after the company announced it signed a research collaboration agreement with the National Cancer Center of Singapore. The project will use the company&#8217;s sequencing technologies.</li>
<li>Conduit Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares were also up, gaining 9% to $0.1119 after AstraZeneca reported a 9.9% stake in the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares dropped 8% to $218.97 following its Cybercab unveiling, with investors assessing a potential 2026 or 2027 timeline.</li>
<li>Shares of Perspective Therapeutics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CATX#NYSE">CATX</a>) were down 8% to $12.20. Perspective Therapeutics announced plans to advance development of radiopharmaceutical therapy [212Pb]VMT01 after data at Society for Melanoma Research Congress.</li>
<li>A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) was down, falling 7% to $80.33 after the company reported preliminary third-quarter results below estimates and cut its FY24 EPS guidance below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $75.49 while gold traded up 1.3% at $2,673.40.
Silver traded up 1.4% to $31.675 on Friday, while copper rose 1.4% to $4.4875.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 0.55%, Germany's DAX gained 0.85% and France's CAC 40 rose 0.48%. Spain's IBEX 35 Index rose 0.54%, while London's FTSE 100 rose 0.19%.
The UK&#8217;s trade deficit shrank to £0.96 billion in August compared to a revised £4.71 billion gap in July, while the British economy grew by 0.2% month-over-month in August. Industrial production in the UK climbed 0.5% month-over-month in August. The annual inflation rate in Germany fell to 1.6% in September from 1.9% in August
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.57%, China's Shanghai Composite Index dipping 2.55% and India's BSE Sensex falling 0.28%.
Industrial production in India fell 0.1% year-over-year in August compared to a revised 4.7% gain in July.
Economics
<ul>
<li>Core producer prices in the U.S. increased by 0.2% from the previous month for September compared to a 0.3% rise in August.</li>
<li>The University of Michigan consumer sentiment fell to 68.9 in October versus a five-month high level of 70.1 in September, and compared to market estimates of 70.8.</li>
<li>The total number of active U.S. oil rigs rose by two to 481 rigs this week, Baker Hughes Inc reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41290782/cvs-has-real-value-jim-cramer-says-micron-had-an-amazing-quarter"> CVS Has &#8216;Real Value,&#8217; Jim Cramer Says: Micron Had An &#8216;Amazing&#8217; Quarter</a></li>
</ul>

Equities

Eurozone

Commodities

CATX

PACB

TSLA

S&P 500 Moves Higher; BlackRock Reports Upbeat Results

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 250 points on Friday.
The Dow traded up 0.63% to 42,722.78 while the NASDAQ rose 0.14% to 18,306.94. The S&amp;P 500 also rose, gaining, 0.39% to 5,802.82.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41290375/how-to-earn-500-a-month-from-bank-of-america-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Bank of America Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares jumped by 2% on Friday.
In trading on Friday, consumer discretionary shares rose by just 0.1%.
Top Headline
Shares of Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) gained more than 5% on Friday after the company reported better-than-expected earnings for its third quarter.
It reported a GAAP EPS of $1.42, beating the consensus of $1.28. Revenue fell 2% to $20.37 billion. Analysts expected $20.41 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) shares shot up 156% to $5.40. The company priced its $10.8 million public offering of 27 million ordinary shares at $0.40 per share.</li>
<li>Shares of Pacific Biosciences of California Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) got a boost, surging 14% to $1.76 after the company announced it signed a research collaboration agreement with the National Cancer Center of Singapore. The project will use the company&#8217;s sequencing technologies.</li>
<li>Conduit Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares were also up, gaining 44% to $0.1472 after AstraZeneca reported a 9.9% stake in the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares dropped 8% to $220.01 following its Cybercab unveiling, with investors assessing a potential 2026 or 2027 timeline.</li>
<li>Shares of Perspective Therapeutics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CATX#NYSE">CATX</a>) were down 15% to $11.32. Perspective Therapeutics announced plans to advance development of radiopharmaceutical therapy [212Pb]VMT01 after data at Society for Melanoma Research Congress.</li>
<li>A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) was down, falling 6% to $81.42 after the company reported preliminary third-quarter results below estimates and cut its FY24 EPS guidance below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $75.44 while gold traded up 1.1% at $2,667.70.
Silver traded up 1.5% to $31.705 on Friday, while copper rose 1.1% to $4.4780.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.61%, Germany's DAX gained 0.77% and France's CAC 40 rose 0.61%. Spain's IBEX 35 Index rose 0.56%, while London's FTSE 100 rose 0.29%.
The UK&#8217;s trade deficit shrank to £0.96 billion in August compared to a revised £4.71 billion gap in July, while the British economy grew by 0.2% month-over-month in August. Industrial production in the UK climbed 0.5% month-over-month in August. The annual inflation rate in Germany fell to 1.6% in September from 1.9% in August
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.57%, China's Shanghai Composite Index dipping 2.55% and India's BSE Sensex falling 0.28%.
Industrial production in India fell 0.1% year-over-year in August compared to a revised 4.7% gain in July.
Economics
<ul>
<li>Core producer prices in the U.S. increased by 0.2% from the previous month for September compared to a 0.3% rise in August.</li>
<li>The University of Michigan consumer sentiment fell to 68.9 in October versus a five-month high level of 70.1 in September, and compared to market estimates of 70.8.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41290782/cvs-has-real-value-jim-cramer-says-micron-had-an-amazing-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41290782/cvs-has-real-value-jim-cramer-says-micron-had-an-amazing-quarter">CVS Has &#8216;Real Value,&#8217; Jim Cramer Says: Micron Had An &#8216;Amazing&#8217; Quarter</a></li>
</ul>

Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings

A.O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) shares are trading lower after the company reported preliminary third-quarter results below estimates and cut its FY24 <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41288440/a-o-smith-announces-preliminary-third-quarter-results-and-provides-revised-2024-full-year-guidance" rel="noreferrer noopener">EPS guidance below estimates</a>.
The company expects third-quarter sales of $902.6 million (vs. consensus of $957.73 million), reflecting a 4% Y/Y decline attributed to lower sales in China and North America's water heating segment.
Also, A. O. Smith sees third-quarter EPS of&nbsp;$0.82&nbsp;(vs.&nbsp;$0.95 estimate), down&nbsp;9%&nbsp;Y/Y.
For North America, the company sees third-quarter sales of $703 million, down from $710 million in 2023, primarily due to lower residential and commercial water heater sales in North America.
In the Rest of World segment, sales were $210 million, down 10% Y/Y, as China saw a 17% drop in local currency sales due to lower volumes of core products, while India reported a 12% increase driven by strong demand.
For the first nine months of 2024, the company generated preliminary cash from operations of $360 million and preliminary free cash flow of $283 million.
Moreover, A. O. Smith trimmed the FY24 EPS&nbsp;outlook from&nbsp;$3.95&nbsp;&#8211;&nbsp;$4.10&nbsp;to&nbsp;$3.70&nbsp;&#8211; $3.85 (vs. consensus of $4.06) and sales guidance to $3.80 billion &#8211; $3.90 billion <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/n39902093/a-o-smith-reports-record-sales-in-the-second-quarter" rel="noreferrer noopener">(from &nbsp;$3.97 billion &#8211; $4.05 billion earlier)</a>.
As mentioned during the second-quarter earnings call, the company witnessed rising consumer demand headwinds in July, prompting caution for the second half of the year in China.
The company stated that these challenges proved to be more severe than anticipated in the third quarter, leading to a 17% decline in constant currency sales to third parties compared to last year.
Kevin J. Wheeler, chairman and chief executive officer added, &#8221;We expect quarter-over-quarter improvement in&nbsp;North America&nbsp;water heater volumes in the fourth quarter; however, we project the softness in&nbsp;China&nbsp;will persist through the remainder of 2024.&#8221;
&#8220;As we have in the past, we are reviewing our operations in&nbsp;China&nbsp;and taking measures to optimize that business to align with the lower volumes&#8230;In&nbsp;North America, we expect improved volumes through the rest of the year. However, we remain cautious about residential and commercial water heater end market demand.&#8221;
This month, the board of directors approved a 6% dividend increase to $0.34, leading to a compound annual dividend growth rate<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41219493/a-o-smith-increases-quarterly-dividend-to-0-34-per-share" rel="noreferrer noopener"> of 8% over the past five years</a>.
Investors can gain exposure to the stock via&nbsp;Global X Clean Water ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQWA#NASDAQ">AQWA</a>) and Tortoise Global Water ESG Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBLU#NYSE">TBLU</a>).
Price Action: AOS shares are down 6.81% at $80.39 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41293190" target="_blank" rel="noreferrer noopener">US Banks Top Q3 Earnings Estimates: JPMorgan Delivers &#8216;Robust Beat,&#8217; Financial Sector Stocks Hit Record Highs</a></li>
</ul>

Movers

AQWA

TBLU

A.O. Smith Slashes FY24 Guidance As China Woes And Weak Water Heater Sales Drag Q3 Performance

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell sharply in today's pre-market trading on brokerage firm Robinhood after the company's robotaxi unveiling event late on Thursday <a href="https://www.benzinga.com/news/24/10/41285210/tesla-stock-falls-nearly-3-in-overnight-trading-on-robinhood-after-self-driving-cybercab-unveil">failed to give investors' confidence</a>.
Tesla on Thursday unveiled a two-seater Cybercab that can drive itself and a robovan with no pedals that can accommodate about 20 passengers at an event in Los Angeles on Thursday. The event, however, was thin on details with the company not divulging the cost of the robovan. Musk also said that the smaller Cybercab will join the company's autonomous taxi fleet only by 2026. The CEO further remarked that he is often optimistic about timelines, hinting at chances of delay.
Tesla shares fell 5.6% to $225.35 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) shares fell 10.6% to $0.66 in pre-market trading after dipping 5% on Thursday.</li>
<li>Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) shares declined 9.9% to $4.83 in pre-market trading.</li>
<li>A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) declined 9.4% to $78.16 in pre-market trading after the company lowered its FY24 earnings forecast.</li>
<li>Nyxoah S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) shares fell 8.3% to $8.71 in pre-market trading.</li>
<li>Indivior PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NYSE">INDV</a>) fell 7.3% to $7.40 in pre-market trading. Indivior shares dipped over 15% on Thursday after the company reported preliminary third-quarter revenue guidance and cut its FY24 net revenue guidance below estimates.</li>
<li>Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) shares dipped 7.3% to $10.60 after gaining around 8% on Thursday.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) fell 5.7% to $7.65 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41272079/top-2-health-care-stocks-that-are-ticking-portfolio-bombs">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

HSAI

INDV

LILM

NYXH

TIGR

Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session

High-Quality Dividend Growth Stocks Near 52-Week Lows: Pfizer Is Fun

The Dividend Aristocrats Ranked By Quality Scores: November 2024

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President-...

Trump Trade: Analyst moves to sidelines on Capital One after Trump rally

Masco Corporation: Still Not Cheap Enough, Especially Given Mixed Results

Stifel analyst Nathan Jones lowered the firm's price target on A.O. Smith (AOS) to $90 from $91 and keeps a Buy rating on the shares. Global indust...

A.O. Smith price target lowered to $90 from $91 at Stifel

These 3 Dividend Aristocrats have raised their dividends for over 25 years and have long-term growth potential.

3 Dividend Aristocrats With Long-Term Growth

PRN: Industrials Dashboard For December

A.O. Smith: Investors Should Wait For Demand To Return And A Better Entry Point

A. O. Smith Corporation In Hot Water

A. O. Smith: It's Worth Looking Past The Bad News

ABBV

AGNC

ALLE

ALLY

AMCCF

AMCR

AXON

BLDR

CHRW

CINF

CTAS

DNOW

ESNT

EXPD

FAST

FCNCA

FIDU

FOUR

GHLD

GTES

KLAC

KREF

KVUE

LDOS

LECO

LRCX

NAVI

NDSN

NEEXU

NMIH

SOFI

SPGI

TROW

Press Releases

A. O. Smith to Hold Second Quarter Conference Call on July 23, 2024

Dividends

A. O. Smith Reports Quarterly Dividend

A. O. Smith to Acquire Pureit, a Leading Water Purification Business in South Asia

A. O. Smith Reports Record Sales in the Second Quarter

A. O. Smith to Hold Third Quarter Conference Call on October 22, 2024

A. O. Smith Increases Quarterly Dividend to $0.34 per Share

A. O. Smith Announces Preliminary Third Quarter Results and Provides Revised 2024 Full Year Guidance

Comments

A.O. Smith

Noticias

Últimas noticias sobre A.O. Smith (NYSE:AOS) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL